美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE	200406	002	ANDA	LAMIVUDINE	TABLET; ORAL	300MG	No	No	2012/05/30 (TA)	--	MICRO LABS LTD	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	202814	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET, FOR SUSPENSION; ORAL	30MG; 60MG	No	No	2012/06/15 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	202685	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET, FOR SUSPENSION; ORAL	30MG; 50MG; 60MG	No	No	2012/09/21 (TA)	--	STRIDES ARCOLAB LTD	None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	203076	001	NDA	LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE	TABLET; ORAL SUSPENSION	30MG; 50MG; 60MG	No	No	2012/10/16 (TA)	--	CIPLA LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	203283	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG; 300MG	No	No	2012/11/08 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	202529	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	300MG; 300MG	No	No	2013/05/17 (TA)	--	RANBAXY LABS LTD	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	204505	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TABLET; ORAL	300MG; 300MG; 200MG	No	No	2013/10/18 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE	202912	001	ANDA	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	TABLET;ORAL	EQ 300MG BASE;150MG;300MG	No	Yes	2013/12/05	2013/12/05	LUPIN LTD	Prescription
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE	204568	001	NDA	EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	TABLET; ORAL	600MG	No	No	2013/12/30 (TA)	--	CIPLA	None (Tentative Approval)
LAMIVUDINE	202941	001	ANDA	LAMIVUDINE	TABLET;ORAL	100MG	No	Yes	2014/01/02	2014/01/02	APOTEX	Prescription
LAMIVUDINE	203260	001	ANDA	LAMIVUDINE	TABLET;ORAL	100MG	No	No	2014/01/02	2014/01/02	HETERO LABS LTD V	Prescription
LAMIVUDINE	203277	001	ANDA	LAMIVUDINE	TABLET;ORAL	150MG	No	No	2014/01/06	2014/01/06	HETERO LABS LTD V	Prescription
LAMIVUDINE	203277	002	ANDA	LAMIVUDINE	TABLET;ORAL	300MG	No	No	2014/01/06	2014/01/06	HETERO LABS LTD V	Prescription
LAMIVUDINE AND ZIDOVUDINE	203259	001	ANDA	LAMIVUDINE; ZIDOVUDINE	TABLET;ORAL	150MG;300MG	No	No	2014/02/03	2014/02/03	HETERO LABS LTD V	Prescription
LAMIVUDINE; ZIDOVUDINE	204914	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL SUSPENSION	30MG; 60MG	No	No	2014/02/04 (TA)	--	MYLAN LABS	None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	205355	001	NDA	LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE	TABLET; ORAL	300MG; 300MG; 200MG	No	No	2014/03/14 (TA)	--	HETERO LABS LTD III	None (Tentative Approval)
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	205861	001	NDA	EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE	TABLET;ORAL	600MG;300MG;300MG	No	No	2014/08/14 (TA)	--	MACLEODS PHARMS LTD	None (Tentative Approval)
LAMIVUDINE AND ZIDOVUDINE	204005	001	ANDA	LAMIVUDINE; ZIDOVUDINE	TABLET;ORAL	150MG;300MG	No	No	2014/08/28	2014/08/28	NATCO	Discontinued
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	206040	001	NDA	LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ	TABLET;ORAL	150MG;300MG;600MG	No	No	2014/09/04 (TA)	--	MYLAN LABS LTD	None (Tentative Approval)
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE	206041	001	NDA	ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE	TABLET;ORAL	300MG;100MG;150MG;300MG	No	No	2014/09/04 (TA)	--	MYLAN LABS LTD	None (Tentative Approval)